Population Health Sciences

You are here

Publications

Found 68 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is V  [Clear All Filters]
Journal Article
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Jung H-Y, Unruh MA, Kaushal R, Vest JR.  2015.  Growth Of New York Physician Participation In Meaningful Use Of Electronic Health Records Was Variable, 2011-12.. Health Aff (Millwood). 34(6):1035-43.
Venkatesan T, Levinthal DJ, Tarbell SE, Jaradeh SS, Hasler WL, Issenman RM, Adams KA, Sarosiek I, Stave CD, Sharaf RN et al..  2019.  Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association.. Neurogastroenterol Motil. 31 Suppl 2:e13604.
Veinot TC, Ancker JS, Bakken S.  2019.  Health informatics and health equity: improving our reach and impact.. J Am Med Inform Assoc. 26(8-9):689-695.
Gomez-Arteaga A, Mark TM, Guarneri D, Christos PJ, Gergis U, Greenberg JD, Hsu J, Mayer SA, Niesvizky R, Pearse RN et al..  2019.  High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.. Bone Marrow Transplant.
Unruh MAaron, Jung HYoung, Kaushal R, Vest JR.  2018.  Hospital participation in Meaningful Use and racial disparities in readmissions.. Am J Manag Care. 24(1):38-42.
Scali ST, Beck AW, Sedrakyan A, Mao J, Venermo M, Faizer R, Schermerhorn M, Beiles B, Szeberin Z, Eldrup N et al..  2019.  Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.. Circulation. 140(15):1285-1287.
Slotwiner DJ, Abraham RL, Al-Khatib SM, H Anderson V, T Bunch J, Ferrara MG, Lippman N, Serwer GA, Steiner PR, Tcheng JE et al..  2019.  HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs).. Heart Rhythm. 16(9):e107-e127.
Zhang Y, Hu H, Fokaidis V, V CLewis, Xu J, Zang C, Xu Z, Wang F, Koropsak M, Bian J et al..  2023.  Identifying environmental risk factors for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the recover program.. Environ Adv. 11:100352.
Vest JR, Jung H-Y, Ostrovsky A, Das LTanmoy, McGinty GB.  2015.  Image Sharing Technologies and Reduction of Imaging Utilization: A Systematic Review and Meta-analysis.. J Am Coll Radiol. 12(12 Pt B):1371-1379.e3.
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH et al..  2019.  Immediate outcomes in early life epilepsy: A contemporary account.. Epilepsy Behav. 97:44-50.
D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al..  2019.  Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.
Shellhaas RA, Berg AT, Grinspan ZM, Wusthoff CJ, Millichap JJ, Loddenkemper T, Coryell J, Saneto RP, Chu CJ, Joshi SM et al..  2017.  Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus.. Pediatr Neurol. 75:73-79.
Grossman LV, Creber RMMasterso, Benda NC, Wright D, Vawdrey DK, Ancker JS.  2019.  Interventions to increase patient portal use in vulnerable populations: a systematic review.. J Am Med Inform Assoc. 26(8-9):855-870.
Veinot TC, Ancker JS, Cole-Lewis H, Mynatt ED, Parker AG, Siek KA, Mamykina L.  2019.  Leveling Up: On the Potential of Upstream Health Informatics Interventions to Enhance Health Equity.. Med Care. 57 Suppl 6 Suppl 2:S108-S114.
Sharaf RN, Venkatesan T, Shah R, Levinthal DJ, Tarbell SE, Jaradeh SS, Hasler WL, Issenman RM, Adams KA, Sarosiek I et al..  2019.  Management of cyclic vomiting syndrome in adults: Evidence review.. Neurogastroenterol Motil. 31 Suppl 2:e13605.
Unruh MA, Jung H-Y, Vest JR, Casalino LP, Kaushal R.  2017.  Meaningful Use of Electronic Health Records by Outpatient Physicians and Readmissions of Medicare Fee-for-Service Beneficiaries.. Med Care. 55(5):493-499.
Ding T, Song T, Zhou B, Geber A, Ma Y, Zhang L, Volk M, Kapadia SN, Jenkins SG, Salvatore M et al..  2019.  Microbial Composition of the Human Nasopharynx Varies According to Influenza Virus Type and Vaccination Status.. MBio. 10(4)
Lin M, Liu L, Gorden M, Kass M, Van Tassel S, Wang F, Peng Y.  2022.  Multi-scale Multi-structure Siamese Network (MMSNet) for Primary Open-Angle Glaucoma Prediction.. Mach Learn Med Imaging. 13583:436-445.
Molina AM, van der Mijn JC, Christos P, Wright J, Thomas C, Dutcher JP, Nanus DM, Tagawa ST, Gudas LJ.  2020.  NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.. Invest New Drugs.
Vina ER, Hannon MJ, Masood H, Hausmann LRM, Ibrahim SA, Dagnino J, Arellano A, C Kwoh K.  2019.  Non-steroidal Anti-inflammatory Drug Use in Chronic Arthritis Pain: Variations by Ethnicity.. Am J Med.
Vest JR, Kern LM, Jung H-Y, Ancker JS, Richardson JE, Silver MD, Kaushal R.  2015.  Patient-centered medical homes: observable types derived from national recognition assessment scores.. J Ambul Care Manage. 38(2):144-52.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.